of glomerular filtration and tubular reabsorption. bodies secreted by B cells greatly amplify the phagocytosis of foreign material through a process called opsonization.
On their way to sites of antigen challenge (microbial invasion, transplanted tissue, vaccine deposit) leukocytes have to cross vascular endothelial cells. Adhesion molecules in concert with chemokines play an essential role in leukocyte recruitment to secondary lymphoid organs as well as to peripheral tissue. Transmigration through the endothelium brings leukocytes into close contact with vascular cells. After this intimate interaction, leukocytes may further emigrate into parenchymal tissue. However, under certain circumstances the subendothelial space itself becomes a site of inflammation, such as in vasculitis, alloimmune vasculopathy, or arteriosclerosis. Endothelial cells are activated by proinflammatory cytokines to express adhesion molecules as well as high levels of antigen-presenting molecules (MHC class I and II). Adhesion molecules facilitate leukocyte recruitment. When endothelial cells express an antigen, they may become a direct target of leukocyte-derived effector molecules and finally succumb.
Adhesion molecules are involved in rolling, firm adhesion, and transmigration of leukocytes
The physiological role of leukocyte adhesion molecules has been elucidated by the study of a particular human disease: leukocyte adhesion deficiency (LAD). Patients with inherited LAD disorders suffer from recurrent, severe bacterial infections due to a failure to recruit granulocytes to the site of microbial invasion. CD18, the common β-chain of three intracellular adhesion molecule (ICAM)-1 ligands [lymphocyte functionassociated antigen-1 (LFA)-1, Mac-1, and p150,95] is mutated in patients suffering from LAD-1 (15) . As a consequence of this defect, ICAM-1 ligands are virtually absent on the surface of leukocytes, and firm adhesion to vascular endothelium (a prerequisite for granulocyte evasion into tissues) is impossible.
Patients with LAD have recurrent bacterial infections, suggestive of granulocyte dysfunction, but no obvious deficiency in antigen-specific immune responses. The recruitment of antigen-specific effector T cells to peripheral tissues is an important step in transplant rejection and graft vs. host disease, infection with intracellular pathogens (e.g., viruses), hypersensitivity reactions, and certain autoimmune disorders. Whereas the LFA-1/ICAM-1 interaction and CD15-E/P-selectin interaction are critical in neutrophil recruitment, lymphocyte recruitment to sites of antigen exposure involves additional or even redundant steps. This view is supported by the analysis of murine CD11a knockout lymphocyte (deficient in LFA-1) recruitment to secondary lymphoid organs (2) . This study reveals a dominant role of LFA-1 in the recruitment to peripheral lymph nodes but not to the spleen. In addition, α 4 -integrins can compensate for the lack of LFA-1. Vascular endothelial cell adhesion molecule (VCAM)-1 is the preferred α 4 -integrin ligand in peripheral lymph nodes, whereas mucosa addressin cell adhesion molecule-1 is involved in recruitment to mesenteric lymph nodes and Peyer's patches. VCAM-1 and ICAM-1, but not the selectins, have been shown to represent the dominant 
Chemokines govern leukocyte recruitment by activation of integrins
Leukocyte recruitment to peripheral tissues involves rolling, firm adhesion, and transmigration. Chemokines, synthesized at sites of inflammation or in secondary lymphoid organs, mediate rapid integrin activation through receptor-mediated activation of a pertussis toxin-sensitive α-subunit of G i (for review, see Refs. 5 and 10). This G protein-dependent step supports firm adhesion of leukocytes to endothelial adhesion molecules VCAM-1 and ICAM-1. Complementary to site-specific adhesion molecule expression, they play an important role in directing leukocyte subsets to sites of inflammation or antigen exposure. In contrast to adhesion molecule deficiencies, which lead to increased susceptibility for bacterial infections, chemokine deficiencies are not known to cause congenital human immunodeficiencies. This suggests that in humans the chemokine system is organized in a redundant way. This view is also confirmed by the promiscuous nature of most chemokine receptors. Granulocytes are activated by a variety of chemokines such as interleukin-8, platelet activating factor, complement component 5a, leukotriene B4, and so forth. Under flow conditions, monocytes are activated by macrophage chemoattractant protein (MCP)-1 and interleukin-8 and lymphocytes are activated by stromal cell-derived factor 1α, 6Ckine, and macrophage inflammatory protein (MIP)-3β to firmly adhere to cytokine-activated endothelial cells or purified ICAM-1. In a murine model of listeria infection, MIP-1α was shown to be critical in mediating protection against a lethal infection by sensitized CD8 T lymphocytes (7). The precise cellular source of chemokines is often unknown. However, activated vascular endothelial cells have been shown to synthesize and secrete interleukin-8, MCP-3, MCP-1, and others.
Chronic vascular inflammation: a rare disorder or a common disease?
After extravasation, leukocytes normally leave the perivascular area immediately to reach foci of antigen exposure or inflammation. In certain immune complex diseases, neutrophil granulocytes are recruited preferentially to the subendothelial and perivascular area, leading to so-called leukocytoclastic vasculitis. In solid organ transplantation and after allogeneic bone marrow/stem cell transplantation, vascular endothelial cells are antigen-bearing cells and therefore potential targets of alloantigen-specific lymphocytes. Under these circumstances, subendothelial lymphocytic infiltrates, called intimal arteritis or endothelialitis, are observed. It is not known which adhesion molecules and chemokines are involved in the accumulation of these predominantly CD8 lymphocytes in the intimal or pericapillary space. In solid organ transplantation, acute endothelialitis is recognized to be the harbinger of severe transplant rejection (6) . Generally, antigen-specific immune attack leads to the rapid antibody-or cell-mediated elimination of antigenbearing cells. In the case of vascular endothelial cells, this would precipitate fibrinoid vessel wall necrosis and thrombus formation and would severely compromise organ perfusion. Under immunosuppressive treatment, this fatal course can be slowed. However, persistent vascular lymphocytic inflammation is thought to sustain the development of transplant-associated arteriosclerosis or chronic graft vs. host disease.
A series of recently published experiments focus on interferon-γ as an important mediator of this chronic fibrotic vasculopathy in solid organ transplantation. When allogeneic hearts were transplanted into interferon-γ-deficient murine recipients, the development of graft vasculopathy was profoundly suppressed (13) . Furthermore, the arteries showed virtually absent CD8 T cells and markedly reduced expression of VCAM-1 and ICAM-1. In a huSCID mouse model of transplant vasculopathy, a human artery is interposed in the murine abdominal aorta. Human interferon-γ was shown to be sufficient to induce intimal hyperplasia (16) indistinguishable from transplant-associated arteriosclerosis. This effect is presumably mediated through local expression of platelet-derived growth factor and its receptor.
To characterize the molecular events that are involved in lymphocyte-endothelial cell interactions during a perivascular immune reaction, we cultured purified CD8 T lymphocytes with allogeneic vascular endothelial cells in the presence of exogenous interleukin-2 (3). In this in vitro system we observed the differentiation of CD8 T lymphocytes into allospecific, MHC class I-restricted CTL. Furthermore, vascular endothelial cells supported the emergence of endothelial cell-selective CTL lines. By cloning these lines we were able to demonstrate that cell type selectivity is a stable property of endothelial-stimulated CTL and not a transient regulatory effect of the coculture (4). We further showed at the clonal level that these endothelial cell-stimulated cells persistently express certain early activation markers, such as interleukin-2 receptor (CD25), and an important costimulatory molecule, CD40L, a member of the tumor necrosis factor (TNF) family. This early activation phenotype has been confirmed in the polyclonal endothelial cell-stimulated CD8 T cells as well. Endothelial cell-stimulated CTL are poor secretors of cytokine, TNF, and interferon-γ, and therefore intact endothelial cells may suppress the profibrotic activity of proinflammatory cytokines in the subendothelial microenvironment. Endothelial cells also profoundly suppress CD8 T cell activation by professional antigen-presenting cells. The physiological significance of endothelial cells as guardians of an anti-inflammatory vascular state adds a fascinating novel aspect to the manifold roles of these cells in maintaining tissue homeostasis.
It is intriguing to speculate that immunoregulatory events are also involved in a much more common vascular disorder: arteriosclerosis (Fig. 2) . In the western world, ~50% of people die from arteriosclerosis-related disease. An important role for activated inflammatory cells, T lymphocytes and macrophages in particular, has been proposed at all stages of the "…leukocytes normally leave the perivascular area immediately to reach foci of antigen exposure.…" disease (14) . It is remarkable that inflammatory genes and leukocyte adhesion molecules are upregulated in the fibrous cap of atherosclerotic plaques compared with the tunica media of the artery (12) . Of a series of transcription factors, early growth response gene-1 (egr-1) was elevated in these lesions. Its binding sites can be found in the promoter regions of a series of injury response genes, and it induces transcription of growth factors [PDGF-A and -B, transforming growth factor-β1], cytokines (TNF, interleukin-2), cell cycle regulators (e.g., p53), and adhesion molecules (e.g., ICAM-1) in reporter assays in vitro. It is hypothesized that a deregulated inflammatory response is involved in arteriosclerosis and drives lesion progression or destabilization. This hypothesis is supported by the fact that CD40L can be detected in atherosclerotic lesions. CD40L is an important activator molecule of dendritic cells and B cells, initiating antigen-specific immune responses and isotype switch of immunoglobulins involved in affinity maturation. CD40L deficiency causes a rare form of immunodeficiency, the X-linked hyper-IgM syndrome. Patients with this disease suffer from recurrent bacterial and fungal infections, suggesting a combined B and T lymphocyte defect. In atherosclerotic lesions, CD40L is not only detected in leukocytes but also in endothelial and smooth muscle cells (11) . Inhibition of CD40-CD40L interaction stops lesion progression in murine models of arteriosclerosis. CD40 signaling in endothelial cells mediates expression of procoagulant tissue factor and therefore challenges one of the tissue-protecting qualities of vascular endothelium: to provide an anticoagulant endovascular surface. The presence of proinflammatory signaling molecules in lesions of chronic vascular diseases such as transplant-associated vasculopathy and arteriosclerosis still does not prove that they are initiating the disease. These molecules might just be coincidentally present in lesions of arteriosclerosis and not even actively involved in the pathological process of lipid accumulation, vessel wall degeneration, and remodeling. Unless drugs can selectively target these proinflammatory mediators, and unless clinical trials will prove the efficacy of these drugs in reducing morbidity and mortality, their significance in sustaining human disease remains a fascinating hypothesis.
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A lthough the contractile performance of the heart is under continuous nervous, hormonal, and electrophysiological influence, the heart has intrinsic mechanisms by which it can adapt cardiac output to changing hemodynamic conditions. An increase in ventricular end diastolic volume (EDV), induced either by increasing aortic resistance to ejection or venous return, immediately leads to a more powerful contraction. This is the well known Frank-Starling mechanism that allows the heart to increase its output after the increase in venous return or to eject the same stroke volume against a greater afterload when an increase in arterial pressure takes place. However, over the next 10 or 15 min after the sudden stretch, there is a further increase in myocardial performance and EDV returns toward its original value (Fig. 1) . The time constant of the phenomenon will depend on several factors, such as species differences, temperature, coronary blood flow, and so forth. Von Anrep (15) showed in 1912 that a heart dilatation induced by clamping the heart outflow was followed by a decline in heart volume toward the initial volume. His interpretation was that, perhaps, the decrease in the flow to the adrenal glands induced the release of catecholamines and a positive inotropic effect. In 1959, Rosenblueth et al. (11) called attention to the fact that both an increase in heart rate (Bowditch effect) and an increase in afterload triggered increases in contractility of the isolated canine right ventricle. They coined the expression "the twostaircase phenomenon." Sarnoff et al. (13) , in 1960, coined the term "homeometric autoregulation" to define the decrease in left ventricular EDV that occurs after the increase in diastolic volume induced by an increase in afterload. Since both reports (11, 13) were based on experiments performed in isolated hearts, the possibility of a positive inotropic effect due to the release of catecholamines by the adrenal glands was ruled out.
In 1973, Parmley and Chuck (10) reproduced this phenomenon in isolated strips of ventricular myocardium. They showed that if the length of the muscle was increased, there were corresponding rapid and slow increases in developed force (1) . The rapid change in force is thought to be the basis of the FrankStarling mechanism and is induced by an increase in the myofilament Ca 2+ sensitivity. The slow force response (SFR) to
